Encyclopedia of Drug Metabolism and Interactions

Editor: Lyubimov, Alexander V.
Publication Year: 2012
Publisher: Wiley

Single-User Purchase Price: $1965.00
Unlimited-User Purchase Price: $2947.50
ISBN: 978-0-47-045015-4
Category: Health & Medicine - Pharmaceutical Science
Image Count: 964
Book Status: Available
Table of Contents

The Encyclopedia of Drug Metabolism and Interactions provides essential support during all phases of drug development, from drug design to drug action and interaction in patients.

Share this

This book is found in the following Credo Collections:

Table of Contents

  • Part 1: Basics Overview of Drug Metabolism
  • Chapter 1 Review of Drug Metabolism in Drug Discovery and Development
  • Chapter 2 In Vitro and In Vivo Models of Drug Metabolism
  • Chapter 3 Enzyme Kinetics of Drug-Metabolizing Reactions and Drug–Drug Interactions
  • Chapter 4 Sex Differences in Drug Metabolism
  • Chapter 5 Species Differences of Drug-Metabolizing Enzymes
  • Part II: Enzyme Systems Involved in Drug Metabolism and Interactions in Animals and Humans
  • Chapter 6 Structure and Function of Cytochrome P450 Enzymes
  • Chapter 7 Mechanisms of Cytochrome P450-Mediated Reactions
  • Chapter 8 Transcriptional Regulation of Cytochrome P450 Genes
  • Chapter 9 Cytochrome P450 Polymorphisms
  • Chapter 10 Flavin-Containing Monooxygenase: The Role of Flavin-Containing Monooxgenase in Lead Design and Selection
  • Chapter 11 Molybdenum-Containing Hydroxylases
  • Chapter 12 Amine Oxidases and Reductases
  • Chapter 13 Epoxide Hydrolases
  • Chapter 14 Carboxylesterases
  • Chapter 15 UDP-Glucuronosyltransferases: Pharmacogenetics, Functional Characterization, and Clinical Relevance
  • Chapter 16 Sulfotransferases
  • Chapter 17 Functional Genomics of the Human Glutathione Transferases
  • Chapter 18 Amino Acid Conjugation: A Novel Route of Xenobiotic Carboxylic Acid Metabolism in Man
  • Part III: General principals of ADME. Drug Transporters and Other Mechanisms of Transport
  • Chapter 1 ADME Profiling in Drug Discovery and Development: An Overview
  • Chapter 2 Anatomical and Physiological Parameters that Influence Gastrointestinal Absorption
  • Chapter 3 Oral Absorption: from Physiology to Regulatory
  • Chapter 4 General Principles of Drug Distribution
  • Chapter 5 ABC Drug Transporters and Their Impact on Drug Disposition/Drug Sensitivity and Resistance
  • Chapter 6 Solute Carrier (SLC) Family Transporters
  • Chapter 7 Mechanisms of Drug Metabolism
  • Chapter 8 Extrahepatic Drug-Metabolizing Enzymes and Their Significance
  • Chapter 9 Mass Balance Studies in Animals and Humans
  • Chapter 10 Bioavailability and Bioequivalence
  • Chapter 11 Interspecies Pharmacokinetic Scaling and the Prediction of Human Pharmacokinetics Using Animal and Cell Models
  • Chapter 12 The Significance and Determination of Plasma Protein Binding
  • Chapter 13 Excretion Systems
  • Chapter 14 Pharmacokinetics and Toxicokinetics in Drug Discovery and Development
  • Chapter 15 Pharmacokinetic Data Analysis and Modeling of ADME Processes
  • Chapter 16 Physiologically Based Pharmacokinetic (PBPK) Modeling: Usefulness and Applications
  • Chapter 17 Pharmacodynamics
  • Chapter 18 Translational Drug Discovery Research: Integration of Medicinal Chemistry, Computational Modeling, Pharmacology, ADME, and Toxicology
  • Part IV: ADME of Some Specific Groups of Drugs and Delivery Systems
  • Chapter 19 ADME of Herbal Dietary Supplements
  • Chapter 20 ADME of Anticancer Drugs
  • Chapter 21 ADME of Cardiovascular Drugs
  • Chapter 22 Disposition of Biological Therapeutics: Monoclonal Antibodies, Proteins, and Peptides
  • Chapter 23 ADME of Natural Toxins
  • Chapter 24 Influence of Changes in Physiology, Transporters, and Enzyme Expression on Disposition and Metabolism of Drugs during Pregnancy and Clinical Implications
  • Part V: Drug Design and Development
  • Chapter 1 When and How to Apply ADMET Principles to Drug Discovery and Development
  • Chapter 2 Molecular Challenges in Front-Loading Toxicity Testing of Anticancer Drugs in Drug Discovery
  • Chapter 3 Role of ADME Studies in Selecting Drug Candidates: Dependence of ADME Parameters on Physicochemical Properties
  • Chapter 4 Effective Early Drug Development
  • Chapter 5 Identification of Drug Metabolites
  • Chapter 6 Drug Bioactivation and Oxidative Stress
  • Chapter 7 Drug Metabolism in Drug Safety Evaluation
  • Part VI: Methods and Protocols for Prediction and Evaluation of Drug Metabolism and Drug Interaction Studies
  • Chapter 8 In Silico Models of Drug Metabolism and Drug Interactions
  • Chapter 9 Methods for Determination of Enzyme Kinetics and Metabolic Rates
  • Chapter 10 Utility of Molecular-Based In Vitro Assays in Metabolic Liability of Drug Candidates
  • Chapter 11 Applications Using Caco-2 and TC7 Cells for Drug Metabolism Studies
  • Chapter 12 In Vitro Liver Systems to Study Induction/Inhibition: Prediction of In Vivo Metabolism and Drug–Drug Interactions
  • Chapter 13 Assessing the Hepatic Disposition and Toxicity of Xenobiotics Using Primary Hepatocytes
  • Chapter 14 Monoclonal Antibody Analyses of Microsomal Human Drug Metabolism and Multifunctional Cytochrome P450
  • Chapter 15 Precision-Cut Tissue Slices: A Suitable In Vitro System for the Study of the Induction of Drug-Metabolizing Enzyme Systems
  • Chapter 16 The Impact of Solubility and Dissolution Assessment on Formulation Strategy and Implications for Oral Drug Disposition
  • Chapter 17 Integrated Approaches to Blood–Brain Barrier
  • Chapter 18 Why Do We Need In Vivo Models in Drug Metabolism?
  • Chapter 19 Utility of Genetically Modified Animal Models for Drug Metabolism and Drug Transporters
  • Part VII: Role of Metabolism in Toxicology and Pharmacology
  • Chapter 1 Introduction: An Overview of the Role of Metabolism in Drug Toxicity
  • Chapter 2 Bioactivation I: Bioactivation by Cytochrome P450s
  • Chapter 3 Bioactivation II: Phase I (Non-P450)
  • Chapter 4 Bioactivation by Phase-II-Enzyme-Catalyzed Conjugation of Xenobiotics
  • Chapter 5 Covalent Drug–Protein Adducts: An Exploration of Their Role in Drug-Induced Liver and General Organ Toxicity
  • Chapter 6 Safety Testing of Drug Metabolites: A Practical Approach for the Implementation of the MIST Guidance in PKDM
  • Chapter 7 In Vitro Toxicity Screening in Early Drug Discovery: Importance of Metabolism and Reactive Metabolites
  • Chapter 8 The Application of Preclinical Toxicogenomics for Predicting and Understanding Drug-Induced Toxicity and Metabolism
  • Chapter 9 Metabonomics in Understanding Drug Metabolism and Toxicology
  • Chapter 10 Proteomics in Drug Discovery and Development
  • Chapter 11 Stereochemical Elements Associated with Drug Metabolism and Toxicity
  • PART VIII: Influence of Physiological Conditions, Diseases, Drug–Food Interactions, Age, Sex, and Other Factors on Drug Metabolism and Effect
  • Chapter 12 Genetics of Drug Disposition
  • Chapter 13 Drug–Drug Interactions 1: Inhibition
  • Chapter 14 Clinical Implications of CYP Induction-Mediated Drug–Drug Interactions
  • Chapter 15 Age-Dependent Expression of Human Drug-Metabolizing Enzymes
  • Chapter 16 Phytochemical Modulators of Human Drug Metabolism: Drug Interactions with Fruits, Vegetables, and Botanical Dietary Supplements
  • Chapter 17 Idiosyncratic Drug Reactions
  • Chapter 18 Animal Models of Idiosyncratic, Drug-Induced Liver Injury: Emphasis on the Inflammatory Stress Hypothesis
  • Chapter 19 Regulation of Drug Metabolizing Enzymes and Transporters in Infection, Inflammation, and Cancer
  • Part IX: Bioanalytical Methods of Studying Metabolism
  • Chapter 1 Bioanalytical Support for Both In Vitro and In Vivo Assays Across Drug Discovery and Drug Development
  • Chapter 2 General Principles of Mass Spectrometry: GC-MS, LC-MS, and LC-MS/MS
  • Chapter 3 Infusion Nanoelectrospray Ionization Mass Spectrometry
  • Chapter 4 A Perspective on the Evolving Field of Ambient Ionization Mass Spectrometry
  • Chapter 5 Matrix-Assisted Laser Desorption/Ionization
  • Chapter 6 Triple Quadrupole and Quadrupole Ion Trap Mass Spectrometers
  • Chapter 7 Hybrid Mass Analyzers in Drug Metabolism Applications
  • Chapter 8 Imaging Mass Spectrometry
  • Chapter 9 Gas-Phase Ion Mobility-Mass Spectrometry (IM-MS) and Tandem IM-MS/MS Strategies for Metabolism Studies and Metabolomics
  • Chapter 10 Inductively Coupled Plasma Mass Spectrometry for Analysis of Metal-Containing Pharmaceuticals
  • Chapter 11 On-Line Electrochemical/LC-MS Techniques for Profiling and Characterizing Metabolites
  • Chapter 12 Nuclear Magnetic Resonance Spectroscopy for the Study of Drug Metabolism
  • Chapter 13 Whole-Body Autoradiography and Microautoradiography in Drug Discovery and Development
  • Chapter 14 Ligand-Binding Assays
  • Chapter 15 Micellar Electrokinetic Chromatography
  • Chapter 16 Direct Biofluid Analysis Systems
  • Chapter 17 Analytical Method Development and Validation in Accordance to the Regulatory Guidelines
  • Chapter 18 Leveraging Advances in HPLC and Sample Preparation to Maximize DMPK Data Quality
  • Chapter 19 High Throughput Quantitative Mass Spectrometry
  • Chapter 20 The Role of Biomarkers in Drug Discovery and Development: Enabling PK/PD
  • Chapter 21 Bioanalytics for Human Microdosing
  • Chapter 22 Bioactivation and Reactive Metabolite Assays
  • Chapter 23 Plasma Protein Binding Methods in Drug Discovery and Development: Bioanalysis
  • Part X: Clinical Aspects of Drug Metabolism and Interactions
  • Chapter 1 Clinical Aspects of Drug Biotransformation: An Overview
  • Chapter 2 CYP450 Enzymes in Drug Discovery and Development: An Overview
  • Chapter 3 DDI Risk Assessment and Evaluation in Pharmaceutical Development: Interfacing Drug Metabolism and Clinical Pharmacology
  • Chapter 4 Current and Future Tools for Predicting Clinical Drug–Drug Interactions
  • Chapter 5 Predicting Human Biotransformation Pathways
  • Chapter 6 Conjugation, Transport, and Elimination of Drugs in Humans
  • Chapter 7 Role and Clinical Consequences of Human UDP-Glucuronosyltransferases
  • Chapter 8 Herb–Drug and Food–Drug Interactions
  • Chapter 9 Effects of Liver Disease on Drug Metabolism in Humans
  • Chapter 10 Role of Phase I Metabolism in Drug Activation and Clinical Treatment Outcomes
  • Chapter 11 Role of Metabolism in Toxicity of Drugs in Humans
  • Chapter 12 Idiosyncratic Drug Reactions and the Potential Role of Metabolism
  • Part XI Metabolism of Specific Drug Groups and Patient Populations
  • Chapter 13 Metabolism of Psychotropic Drugs
  • Chapter 14 Metabolism-Based Consequences of Polytherapy with Antiepileptic Drugs
  • Chapter 15 Oral Chemotherapeutic Agents
  • Chapter 16 Drug Metabolism and Interactions in Pediatric Patients
  • Chapter 17 Population-Based Pharmacokinetic Modeling and Simulation
  • Chapter 18 Clinical Pharmacology in Drug Labeling. The Impact of Drug Metabolism and Clinical Pharmacology on Recommended Dose of Drugs